Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Molnupiravir: evidence by press release.
Cave, James A; Phizackerley, David.
Drug Ther Bull ; 60(1): 2, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-2157411

Subject(s)
Cytidine , Hydroxylamines , Cytidine/analogs & derivatives , Humans
2.
Three more points about Paxlovid for covid-19.
Phizackerley, David.
BMJ ; 377: o1397, 2022 06 07.
Article in English | MEDLINE | ID: covidwho-1879126

Subject(s)
COVID-19 , Drug Combinations , Humans , Lactams , Leucine , Nitriles , Proline , Ritonavir , SARS-CoV-2
3.
Covid-19 vaccination-we need more than the 'mum test'.
Phizackerley, David.
Drug Ther Bull ; 59(1): 2, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-953577

Subject(s)
COVID-19 Vaccines/supply & distribution , COVID-19/prevention & control , SARS-CoV-2/immunology , Vaccination , Global Health , Humans
4.
Virtual revolution?
Cave, James A; Phizackerley, David.
Drug Ther Bull ; 58(8): 114, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-861635

Subject(s)
General Practice/trends , Primary Health Care/trends , Humans , Pandemics
5.
Deprescribing in the time of covid-19.
Phizackerley, David.
Drug Ther Bull ; 58(6): 82, 2020 06.
Article in English | MEDLINE | ID: covidwho-155439

Subject(s)
Deprescriptions , Diabetes Mellitus , Hypertension , Infections , Betacoronavirus , COVID-19 , Coronavirus Infections , Humans , Pandemics , Pneumonia, Viral , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL